SEC Form D · filed November 2, 2023
Reprise Biomedical, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Heather Kotila · Plymouth, MNExecPhil Nalbone · Plymouth, MNDirectorCarrie Powers · Plymouth, MNExec · DirectorJerrod Krueger · Plymouth, MNExecHoward Root · Plymouth, MNDirectorSteve Jagodzinski · Plymouth, MNExecRonald Eibensteiner · Plymouth, MNDirectorGreg Smock · Plymouth, MNExecJake Isenburg · Plymouth, MNExecErwin Kelen · Plymouth, MNDirectorTina Walters · Plymouth, MNExecHoward Root · Plymouth, MNDirectorGreg Smock · Plymouth, MNExecRonald Eibensteiner · Plymouth, MNDirectorJake Isenburg · Plymouth, MNExecErwin Kelen · Plymouth, MNDirectorTina Walters · Plymouth, MNExecHeather Kotila · Plymouth, MNExecPhil Nalbone · Plymouth, MNDirectorJerrod Krueger · Plymouth, MNExecSteve Jagodzinski · Plymouth, MNExecCarrie Powers · Plymouth, MNExec · DirectorE. Brian Harvey · UPTON, MADirectorJoann Harris · Fort Worth, TXExecSteven A. Willmann · Fort Worth, TXExecJordan A. Kolar · Fort Worth, TXDirectorBradford Berenson · Fort Worth, TXExecNadia A. Karkar · Fort Worth, TXExecDaniel Friedland · DALLAS, TXDirectorKevin Lutz · San Francisco, CAExecVenkatesh Yerramsetty · FLOWER MOUND, TXExec · DirectorRyan Mcdermott · San Francisco, CAExecAndrew Osher · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗